Low-density lipoprotein receptor-related protein 6 (LRP6) serves as a Wnt coreceptor. Although Wnt/LRP6 signalling is best known for the b-catenin-dependent regulation of target genes in tissue development and homeostasis, emerging evidence demonstrates the biological aspects of LRP6 beyond a Wnt coreceptor. Whether 
extensive organ defects and neonatal lethality, which resembles the phenotypes caused by mutations in individual Wnt genes. 4, 5 Moreover, evidence for the pathophysiological relevance of Lrp6 mutation and deficiency, such as Alzheimer disease, coronary artery disease and cardiac ischemia, have emerged, and presumably the aberrant Wnt signalling mediates the functional link. 2, 6 The biological aspects of LRP6 beyond a Wnt coreceptor have been gradually recognized. Our recent study demonstrated a scaffolding role of LRP6 in the membrane targeting of connexin 43 and thus gap junction assembly in the mouse heart. 7 Wan et al reported the property of LRP6 as a trafficking adaptor, showing that Lrp6 knockdown disrupts the localization of Gas to the plasma membrane and impairs a functional G protein-coupled receptor (GPCR) signalling pathway for the production of cAMP. 8 Interestingly, several lines of evidence also documented that a soluble LRP6 intracellular domain can translocate to the nucleus and directly modulates the activity of the Wnt responsive transcription factor TCF/LEF-1, 9, 10 suggesting the potential transcriptional and post-transcriptional activities of LRP6 protein. These reports led us to suspect whether LRP6
modulates tissue development and homeostasis in a Wnt/b-catenin signalling-independent manner, and if so, to delineate the molecular mechanisms.
In the present study, using a well-established model of striated muscle development, 11 we discovered a gradual increase 
| MATERIALS AND METHODS

| Myoblast cell culture and myodifferentiation
The mouse C2C12 myoblasts (CRL-1772, ATCCâ) were grown at low density in Dulbecco's Modified Eagle Medium (DMEM, D6429, Sigma-Aldrich) supplemented with 10% FBS (F7524, Sigma-Aldrich), 100 U/mL penicillin, 100 lg/mL streptomycin and 1% L-glutamine (G7513, Sigma-Aldrich). After reaching 70% confluence, the medium was replaced by DMEM supplemented with 2%
horse serum (26050070, Gibco TM ) to induce myodifferentiation.
The medium was changed every 24 hours before the test. To obtain the knockdown of Lrp6 in C2C12 cells, adenovirusmediated Lrp6 shRNA that targets the sequence GCACTACAT-TAGTTCCAAA and control shRNA (ATAGCTACAATCGCAATCT)
were transfected into cells. To quantify the myodifferentiation, we calculated the fusion index as the average number of nuclei in MHC-positive cells with at least three nuclei above total number of nuclei, and the number of nuclei per myotube was measured using the NIH Image J software.
| Isolation and culture of neonatal rat cardiomyocytes
The isolation and culture of neonatal rat cardiomyocytes (NRCMs)
were performed according to the procedures previously described. 
| Cellular fractionation
Cytoplasmic and total nuclear proteins were extracted using the CelLyticTM NuCLEARTM Extraction Kit (NXTRACT, Sigma) according to the manufacturer's instructions. After nuclei were counterstained with 4, 6-diamidino-2-phenylindole (DAPI, 5 lg/mL), the cells were visualized using a Leica confocal laser-scanning microscope.
| Immunofluorescence microscopy
| mRNA stability assays
Itgb1D mRNAs in NRCMs were quantified relative to 18S rRNA at various times after addition of actinomycin D (ActD, 6.5 lg/mL, Sigma-Aldrich) to the culture medium. Relative quantification values at 0 hour were set to 1.
| Protein purification
To obtain the purified proteins of the full-length LRP6, the vector expressing LRP6 was constructed. The corresponding sequence was amplified from Lrp6 plasmid (Origene) by PCR and was subcloned into the pcDNA3.1 expression vector (Invitrogen) using BamH1 and Xbal restriction sites. The DNA sequence of the flag tag was attached to the C-terminus of Lrp6. The plasmid was transfected into the 293T cells for 48 hours using Lipofectamine3000 (Invitrogen), and the overexpressed LRP6 proteins were purified using FLAGâ M Purification Kit (Sigma).
| Biotinylated RNA pull-down assays
The full-length U1-U6 snRNAs (rat) were transcribed in vitro using T7 RNA polymerase (ThermoFisher), and then were labelled using Pierce RNA 3 0 end desthiobiotinylation kit (ThermoFisher). 150 pM RNA probes were incubated with 50 lL streptavidin magnetic beads (Sigma) at room temperature for 25 minutes. Then, 400 ng of the purified flag-tagged LRP6 fusion proteins were incubated with RNAbeads complex at 4°C for 50 minutes. The proteins bound to U1-U6 snRNAs were stripped by elution buffer and analysed by Western blotting with anti-LRP6 antibody (C5C7, CST).
| Plasmid construction
To construct recombinant vectors of U1-U6 snRNAs, their sequences were amplified from rat cDNAs and subcloned into the pCMV6-entry vector (Origene) using SgfI and XhoI restriction sites. Table S1 .
| Minigene constructs and site-directed oligonucleotide mutation
The minigene constructs were assembled in the pCMV6-entry vector Table S1 .
| Luciferase assays
To measure the transcription activity of Itgb1 gene, pGL3-Itgb1 promoter luciferase reporter vector and pRL-TK (Promega) were cotransfected in the HeLa cells, which were subject to Lrp6 silencing by the targeted siRNAs for 48 hours. After another 24 hours, cells were harvested and analysed using a Dual-Luciferase reporter assay kit (Promega).
| Immunoblotting analysis
Proteins were extracted on ice using a RIPA lysis buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) supplemented with protease inhibitor-cocktail (Roche).
SDS-PAGE and western bolt were performed to analyse the expres- 
| RNA immunoprecipitation
To | 4655 human or rat genome assembly using Tophat (http://tophat.cbcb.
umd.edu/) (version 2.0.9). Aligned reads were then quantified for expression using the Cufflinks suite version 2. 
| Statistical analysis
All data are presented as the means AE standard errors of the mean (SEM). The data shown were the averages of at least three biological replicates. No inclusion/exclusion criteria were used. Statistical analyses were performed using Prism Software (GraphPad). The statistical significance of the difference between two sets of data was assessed using an unpaired, two-tailed Student's t test and one-way ANOVA with Bonferroni's post-hoc test. A P value less than .05 was considered to be significant.
| RESULTS
| LRP6-mediated muscle development couples to the muscle-specific splicing of Itgb1D
To test whether LRP6 modulates tissue development and homeostasis in a Wnt signalling-independent manner, we utilized a C2C12 myoblast model that recapitulates important features of striated muscle development. These myoblasts underwent a program of proliferation and myodifferentiation to form multinucleated myotubes ( Figure 1A ,B). During the proliferative phase, LRP6 protein was barely detectable in C2C12 myoblasts. Its expression prominently increased when myoblasts entered into myodifferentiation, and peaked when myotube formed ( Figure 1C ). The coincidence of the onset of LRP6 expression with the timing of myoblast withdrawal from the cell cycle implied a major function for LRP6 in commitment of differentiating muscle cells, which was evidenced by the findings that LRP6 deficiency greatly retarded, whereas its overexpression promoted, the myotube fusion ( Figure 1D ).
During striated muscle development, integrin-dependent cellmatrix adhesion sets the starting point for myofibrillogenesis. 12 Different splicing isoforms of Itgb1 are differentially expressed in foetal (Itgb1A) and mature muscle cells (Itgb1D), and the latter is essential for myotube fusion. 13, 14 We found that ITGB1D protein was gradually increased in parallel with LRP6 protein during myodifferentiation ( Figure 1E ). LRP6 deficiency down-regulated the expression of ITGB1D protein, but did not affect the total ITGB1 proteins (Figure 1E ). The reduction of ITGB1D proteins was not involved in the transcriptional change of Itgb1 and the degradation of Itgb1D mRNA and protein ( Figure S1 and S2). However, while the overall amount of Itgb1 mRNAs appeared normal, the transcript levels of Itgb1D were decreased and concurrently the expression of Itgb1A mRNAs up-regulated by LRP6 deficiency, suggesting the deregulated splicing switching of Itgb1A to muscle-specific Itgb1D isoforms ( Figure 1F ).
These evidence indicate that LRP6 may act as a trans-acting regulator mediating the functional splicing of Itgb1 pre-mRNAs. 3.3 | LRP6 interacts with the core spliceosome components to direct muscle-specific splicing of Itgb1D in the nucleus of striated muscle cells
As the splicing regulation is well characterized in the eukaryotic nucleus, 15 we expected that LRP6 is physiologically present at appreciable levels in the nucleus. Unexpectedly, LRP6 protein was almost undetectable in the nucleus of C2C12 myoblasts. However, as soon as myodifferentiation commenced, the nuclear expression of LRP6 was dramatically enhanced (Figure 2A) , which was positively pertinent to the degree of myodifferentiation. Interestingly, the nuclear expression of LRP6 protein was constantly detected in some Nuclear pre-mRNA splicing is carried out in the spliceosome, a dynamic RNA-protein complex composed of five small nuclear RNAs (U1/2/4/5/6 snRNAs) together with associated splice factors. 16 At the initial step of splicing, U1 and the U2 auxiliary factors (U2AF) bind to the 5 0 and 3 0 splice site, respectively. Successively, U2 tethers to the branch point, and a preformed complex of U4/5/6 trisnRNPs is recruited to the intron. After release of the U1 and U4, the splicing reaction is catalysed. Using RNA-immunoprecipitation (RIP) and in vitro biotinylated RNA pull-down assays, we identified that LRP6 bond to U4/5/6 snRNAs ( Figure 2B ). In addition, the immunofluorescent staining also revealed the partial co-localization of endogenous LRP6 protein with the splice factors U2AF65, C1 and PTBP1 in the nucleus of HeLa cells ( Figure 2C ). The U2AF65 protein contains a serine/arginine (SR)-rich domain that recruits itself to active splicing sites. 17, 18 These results suggest that LRP6 may function at the catalytic step of splicing.
Moreover, the specific activity of LRP6 on Itgb1 pre-mRNA was confirmed using a splicing reporter minigene in which exclusion of the alternative exon D (AED) contributes to Itgb1's elasticity (Figure 2D ). Considering the case that the efficacy of the minigene expression was low in C2C12 cells, we conducted the activity analy- Using the site-directed mutagenesis, we identified that the nuclear leading sequence (NLS)-mediated expression of the ICD mutant containing a Ser-to-Ala substitution (NLS-ICDMut) induced the exclusion of AED in the neonatal cardiomyocytes expressing wild-type minigene ( Figure 3E ), indicating that the serine residue was critical for the RNA splicing activity. Overall, LRP6 may act primarily as a splicing regulator to facilitate the inclusion of AED within Itgb1 premRNA in striated muscle cells.
| LRP6-mediated AED use is sufficient to overcome exon skipping by splicing repressors
The usage of a particular exon is usually subject to antagonistic factors-mediated bidirectional regulation. 17 Members of the hnRNP family often cause exon exclusion through binding to splicing cis-regulatory elements. 18 During myodifferentiation, the hnRNP A1 (also known as hnRNP I) and PTBP1 exhibited the expression pattern 
| LRP6 guides the global regulation of AS
To determine whether the LRP6-mediated splicing regulation is a more widespread phenomenon, we performed deep RNA sequencing of cells from rat and human. We detected a substantial number of Lrp6 loss-induced alternative splicing events, and up to nearly 50% of them were exon-skipped ( Figure 5A-C) . This LRP6-dependent gene network includes Itgb1, whose alternative splicing was expected based on the above experiments and thus validated our approach. A gene ontology analysis of the conserved LRP6-driven network showed enrichment for 94 genes encoding proteins mainly involved in cellular and metabolic processes ( Figure 5D ). Among them, a decade of genes with LRP6-dependent isoform expression showed identical splicing patterns on the exon level across species (Table S2) . Moreover, we identified that among the 94 genes that are regulated by LRP6 in the three types of cells, only two genes are involved in the Wnt/b-catenin signalling pathway, and 92 genes are not associated with this signalling (Table S2 ). The RNA sequencing results were verified for several additional genes other than Itgb1 ( Figure 5E ). All of these data supported the notion that LRP6 guides the global regulation of alternative splicing. Pre-mRNA splicing is conditionally regulated by signal transduction pathways. 16 Although LRP6 protein has long been thought to mediate the Wnt/b-catenin signalling, our recent findings indicated that LRP6 is not necessary for transducing Wnt signalling in striated muscle cells. 7 Especially, despite the soluble LRP6-ICD has the potential to modulate the activity of b-catenin-coupled transcription factor TCF/LEF-1, affecting the transcription of target genes, 9 we did not observe the effect of LRP6 on Itgb1 transcription ( Figure 1 and Figure S1 ) In sum, our findings identify LRP6 as a potential splicing regulator. The RNA-binding landscape of LRP6 may also provide insights into the post-transcriptional RNA processing, given that RBPs can modulate diverse post-transcriptional processes including mRNA transport, localization, stability and translation, and microRNA inhibition. 21 In addition, the disease-relevant mutations of Lrp6 have been reported in its splicing regulatory C-terminus, 2 and thus there remain 
| DISCUSSION
